404
Multiple Sclerosis Therapeutics Market Report
Multiple Sclerosis Therapeutics Market Trends, Dynamics & Market Insights
Multiple Sclerosis Therapeutics Market, By Drug Type (Immunomodulators, Immunosuppressant, Copaxone, Avonex, Gilenya, Other), Mode of Administration (Oral, Injectable, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, e-Commerce), and Region -...
The Multiple Sclerosis Therapeutics Market is expected to witness an impressive growth of 6.5% CAGR in the coming years?
Novartis International AG (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi Gen-zyme (US), Bayer AG (Germany), Pfizer Inc. (US), Biogen Inc. (US), The Merck Group (Germany) and AbbVie (US) are among the key players in the Multiple Sclerosis Therapeutics Market.
The Multiple Sclerosis Therapeutics Market is expected to reach USD 37.3 billion in the foreseeable future.
The hospital pharmacies segment is expected to register significant growth in the Multiple Sclerosis Therapeutics Market in the coming years.
North America accounted for the largest share in the Multiple Sclerosis Therapeutics Market in 2020.
Multiple sclerosis therapeutics distributors, Multiple sclerosis therapeutics suppliers, Multiple sclerosis therapeutics manufacturers, Logistics organizations, Government bodies are among the target audience in the Multiple Sclerosis Therapeutics Market.